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Summary
Haemolytic uraemic syndrome caused by Shiga
toxin-producing E. coli (STEC) is dependent on
release of Shiga toxins (Stxs) during intestinal
infection and subsequent absorption into the
bloodstream. An understanding of Stx-related
events in the human gut is limited due to lack of
suitable experimental models. In this study, we
have used a vertical diffusion chamber system
with polarized human colon carcinoma cells to
simulate the microaerobic (MA) environment in
the human intestine and investigate its influence
on Stx release and translocation during STEC
O157:H7 and O104:H4 infection. Stx2 was the
major toxin type released during infection.
Whereas microaerobiosis significantly reduced
bacterial growth as well as Stx production and
release into the medium, Stx translocation across
the epithelial monolayer was enhanced under MA
versus aerobic conditions. Increased Stx transport
was dependent on STEC infection and occurred
via a transcellular pathway other than macro-
pinocytosis. While MA conditions had a similar
general effect on Stx release and absorption
during infection with STEC O157:H7 and O104:H4,
both serotypes showed considerable differences
in colonization, Stx production, and Stx transloca-
tion which suggest alternative virulence strategies.
Taken together, our study suggests that the MA
environment in the human colon may modulate
Stx-related events and enhance Stx absorption
during STEC infection.
Introduction
Shiga toxin-producing E. coli (STEC) are the fourth most
common bacterial foodborne pathogen and responsible
for around 1200 illnesses per year in the UK (Money et al.,
2010). While most infections resolve spontaneously after
a period of acute gastroenteritis and/or haemorrhagic
colitis, up to 15% of cases develop haemolytic uraemic
syndrome (HUS), a severe systemic complication that can
be fatal. HUS is the leading cause of acute kidney failure
in children in the western world (Tarr et al., 2005).
Although STEC have been linked to HUS since 1983,
there is still no specific treatment available, and use of
antibiotics remains controversial (Karmali et al., 1983;
Riley et al., 1983; Tarr et al., 2005; Wong et al., 2012).
After ingestion via contaminated food or water, STEC
adhere to human intestinal epithelium and inject bacterial
effector proteins into the host cell through a type III secre-
tion system (T3SS). These effector proteins interfere with
host cell signalling and function (e.g. tight junction integ-
rity and alteration of ion channels) which ultimately leads
to loss of absorptive function and diarrhoea (Viswanathan
et al., 2009; Wong et al., 2011). In addition, STEC
produce Shiga toxins (Stxs) which are strongly associated
with HUS and can be divided into Stx1 and Stx2 and their
subtypes (Karmali et al., 1985; Bergan et al., 2012). Shiga
toxins are encoded by lambdoid prophages on the bacte-
rial chromosome and are not secreted via the T3SS but
released during bacterial lysis after induction of the
phage lytic cycle (Wagner et al., 2001b; 2002). In the host,
Stxs bind to a membrane glycolipid receptor (globotri-
aosylceramie, Gb3) which is highly expressed by
microvascular endothelium in the kidney, the primary
target for Stxs in human disease (Hughes et al., 2002).
After endocytosis, Stxs undergo retrograde transport via
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the Golgi and endoplasmic reticulum before release into
the cytoplasm where they cause cell death by inhibition of
protein synthesis and subsequent apoptosis (Lingwood
et al., 1987; Endo et al., 1988; Tesh, 2012). Most com-
monly used human colon carcinoma cell lines express
Gb3 probably as a consequence of malignant transforma-
tion as Gb3 expression has been linked to cancer
(Kovbasnjuk et al., 2005; Engedal et al., 2011). In con-
trast, normal human intestinal epithelium appears to lack
Gb3 and other Stx binding sites (Björk et al., 1987;
Holgersson et al., 1991; Schüller et al., 2004) although
this has been debated in a recent study (Zumbrun et al.,
2010). It remains unknown how Stxs are absorbed into
the systemic circulation (Schüller, 2011). Several routes of
access such as paracellular leakage during neutrophil
transmigration and STEC translocation via M cells have
been investigated (Hurley et al., 2001; Etienne-Mesmin
et al., 2011), but Gb3-independent transcytosis by intes-
tinal epithelial cells represents the most studied mecha-
nism so far (Acheson et al., 1996; Philpott et al., 1997;
Malyukova et al., 2009). While all transcytosis studies on
polarized Gb3-negative human T84 colon carcinoma cells
have been performed with purified Stx1, we have studied
Stx production, release and translocation during infection
with Stx2-producing STEC O157:H7 and O104:H4 bacte-
rial strains. We have focused on Stx2 as this toxin type is
more closely associated with HUS than Stx1 (Heuvelink
et al., 1995; Boerlin et al., 1999). In addition, we have
employed a microaerobic vertical diffusion chamber
(VDC) system (Schüller and Phillips, 2010) to mimic the
low oxygen environment in the human gut and study
its effect on Stx release and absorption during STEC
infection.
Results
STEC infection of polarized T84 cells in a microaerobic
vertical diffusion chamber
Polarized T84 colon carcinoma cells were mounted in a
VDC and infected apically with STEC O157:H7 strains
EDL933, Walla-1, or an isolate of the 2011 STEC
O104:H4 outbreak in Germany (H1121). Infections were
performed for 5 h under either microaerobic (MA, oxygen
concentration of 1.4–1.7% atmospheric pressure) or
aerobic (AE, 18–20%) conditions on the apical side while
the basal side was kept under aerobic conditions (Fig. 1).
T84 cell integrity and bacterial adherence were investi-
gated by microscopy. XZ scanning confocal microscopy
showed an intact monolayer of columnar shaped T84 cells
with an apical actin-rich brush border indicating cell polari-
zation (Fig. 2A). Tight junction integrity and intact barrier
function during infection were confirmed by occludin stain-
ing (Fig. 2B) and maintenance of stable transepithelial
electrical resistance (TER) (Fig. 2D). Scanning electron
microscopy (SEM) revealed a dense microvillous brush
border particularly on non-infected T84 cells (Fig. 2C).
Small bacterial microcolonies were observed on T84
monolayers infected with EDL933 (Fig. 2C) or Walla-1
(data not shown) with evident microvillous effacement
around adherent bacteria. In contrast, O104:H4 strain
H1121 exhibited extensive adherence of bacterial aggre-
gates. Microvilli around adherent bacteria showed signs
of vesiculation but no effacement (Fig. 2C). T84 cell integ-
rity and bacterial adherence patterns were comparable
under MA and AE conditions.
STEC EDL933 growth and Stx release are reduced
under microaerobic conditions
To examine the effect of a MA environment on bacterial
growth and Stx release into the medium, polarized T84
cells were infected with EDL933 under MA or AE condi-
tions for 3–5 h. Bacterial growth in the apical chamber
was assessed by optical density (OD600) while Stx release
was quantified by Vero cell cytotoxicity assay (VCCA). Stx
cytotoxicity was expressed as equivalent concentration of
purified Stx2 which was used for the standard curve.
Values were adjusted to an OD600 of 0.1 to account for
differences in bacterial density. As shown in Fig. 3A and B,
growth of EDL933 and Stx cytotoxicity in the medium
were significantly reduced under MA versus AE conditions
after 5 h of infection.
Stx2 is the major toxin type released during
EDL933 infection
While the VCCA represents the most sensitive assay
to determine Stx levels according to toxin activity
Fig. 1. Schematic representation of vertical diffusion chamber.
Polarized T84 cells grown on Snapwell filters were inserted
between two half chambers and infected apically with STEC.
Apical chambers were maintained under aerobic or microaerobic
conditions whereas basal compartments were kept under aerobic
conditions (modified from Schüller and Phillips, 2010).
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(cytotoxicity on Vero cells) it cannot distinguish between
Stx1 and Stx2. This is important as EDL933 produces
both toxin types. In addition, Stx activity and actual protein
levels might not be directly correlated, and decreased Stx
cytotoxicity in MA supernatants might be due to loss of
activity rather than diminished toxin release. To quantify
Stx protein levels in apical supernatants, Stx1- and
Stx2-specific sandwich ELISAs were developed and
applied. As before, Stx concentrations in supernatants
were adjusted to OD 0.1 to account for different bacterial
densities in apical media. As shown in Fig. 4A and B, both
Stx1 and Stx2 release were significantly reduced under
MA versus AE conditions. In addition, Stx2 was the pre-
dominant toxin type released into the medium under both
AE and MA conditions (98% and 96% of total Stx respec-
tively). This was corroborated by VCCA neutralization
assays where addition of anti-Stx2 abrogated more than
95% of cytotoxicity from apical supernatants whereas
addition of anti-Stx1 did not show any detectable effect
(Fig. S1).
Stx2 stability and binding to T84 cells are not affected
by oxygen levels
Lower Stx2 concentrations in the apical medium after MA
versus AE EDL933 infection could be caused by reduced
Stx release, lower toxin stability or increased Stx binding
to T84 cells under MA conditions. To investigate the latter
two possibilities, purified Stx2 at a concentration compa-
rable to that released during infection (100 ng ml−1) was
Fig. 2. T84 cell integrity and STEC adherence after 5 h infection.
Shown are representative images from two independent
experiments performed in duplicate (A–C).
A. Confocal XZ scan of T84 cells infected with EDL933. Cell
monolayers were stained for E. coli (red), F-actin (green) and cell
nuclei (blue). Bar = 5 μm.
B. Immunofluorescence staining of non-infected (NI) and
EDL933-infected T84 cells. Cells were stained for occludin (green)
and E. coli (red). Bar = 10 μm.
C. Scanning electron micrographs of non-infected T84 cells (NI)
and cells infected with EDL933 or H1121. Bars = 5 μm (NI), 2 μm
(H1121, left panel) and 1 μm (EDL933; H1121, right panel).
D. TER of non-infected T84 cells (NI) and cells infected with
EDL933, Walla-1 or H1121 under AE (■) or MA (□) conditions.
TER after infection is expressed as percentage of TER before
infection. Data are shown as means ± SEM from seven
independent experiments performed in duplicate.
Fig. 3. Microaerobic conditions reduce STEC EDL933 growth and
Stx release into the apical medium. T84 cells were infected for 3 to
5 h and maintained under AE (●) or MA (□) conditions. Bacterial
growth was assessed by OD600 (A). Stx cytotoxicity in apical
supernatants was determined by VCCA (B). Data are shown as
means ± SEM from three independent experiments performed in
duplicate. *P < 0.05, **P < 0.01.
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incubated with or without polarized T84 cells for 5 h under
AE or MA conditions. Stx2 levels in the apical medium
were quantified by ELISA. As shown in Fig. 5, comparable
amounts of Stx2 were recovered under AE and MA con-
ditions without T84 cells indicating that oxygen levels do
not influence Stx2 stability. In addition, Stx2 concentra-
tions in apical media incubated with or without T84 cells
showed no significant difference, thereby indicating neg-
ligible Stx2 binding to polarized T84 cells under AE or MA
conditions (Fig. 5).
Microaerobiosis reduces bacterial growth and Stx2
release in other STEC strains and decreases Stx1
production in EDL933 lysates
Experiments to study the effect of oxygen on bacterial
growth and Stx2 release were extended to O157:H7 strain
Walla-1 and O104:H4 strain H1121. Both strains produce
the same Stx2 subtype as EDL933 (Stx2a) but do not
produce Stx1. Similar to EDL933, both strains showed
significantly reduced growth and Stx2 supernatant levels
under MA versus AE conditions (Fig. 6A and B). In addi-
tion, aerobic growth of H1121 was significantly lower com-
pared with EDL933 (Fig. 6A) and Stx2 release by Walla-1
Fig. 4. Microaerobiosis decreases Stx release and Stx2 is the main
toxin type in supernatants during EDL933 infection. T84 cells were
infected for 5 h under AE or MA conditions. Stx1 (A) and Stx2
levels (B) in apical supernatants were quantified by Stx
type-specific ELISAs. Data are shown as means ± SEM from five
independent experiments performed in duplicate. **P < 0.01.
Fig. 5. Stx2 stability and T84 cell binding are not affected by
oxygen levels. Purified Stx2 (100 ng ml−1) was incubated for 5 h
with (+ T84) or without polarized T84 cells (− T84) under AE (■) or
MA (□) conditions. Stx2 levels were quantified by ELISA. Data are
shown as means ± SEM from four independent experiments
performed in duplicate.
Fig. 6. Microaerobiosis reduces growth, Stx production and release
in STEC EDL933, Walla-1 and H1121. Polarized T84 cells were
infected for 5 h under AE (■) or MA (□) conditions.
A. Bacterial growth was assessed by OD600. Data are shown as
means ± SEM from five independent experiments performed in
duplicate. **P < 0.01, ***P < 0.001 versus AE conditions; $$P < 0.01
versus EDL933 AE.
B. Stx2 levels in apical supernatants were quantified by ELISA.
Data are shown as means ± SEM from four independent
experiments performed in duplicate. *P < 0.05, **P < 0.01,
***P < 0.001 versus AE; $$$P < 0.001 versus EDL933 AE; &P < 0.05,
&&&P < 0.001 versus EDL933 MA.
C. Stx1 production in bacterial lysates of EDL933 (E), Walla-1 (W)
and H1121(H) under AE (A) and MA (M) conditions was determined
by Western blotting. Amounts of loaded bacterial protein were
assessed by GroEL expression. The marker lane (M) indicates
58 kDa for GroEL and 30 kDa for Stx1. Shown are representative
images from three independent experiments.
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and H1121 was significantly reduced compared with
EDL933 under AE and MA conditions (Fig. 6B).
To investigate whether lower Stx release under MA
conditions was associated with diminished Stx production
within bacteria, Stx expression in bacterial lysates was
examined by Western blot analysis. Stx2 levels in lysates
of all three STEC strains were equally low under AE or MA
conditions and could only be detected after prolonged
exposure times (data not shown). In contrast, Stx1 could
readily be detected in EDL933 lysates and expression
was reduced under MA versus AE conditions (Fig. 6C). As
expected, no Stx1 signal was present in lysates of Walla-1
and H1121.
Stx2 translocation across polarized T84 monolayers is
enhanced by microaerobic STEC infection
To determine whether microaerobiosis affects Stx2 trans-
location across intestinal epithelium, polarized T84 cell
monolayers were infected with EDL933 or H1121 and
VDC incubations were carried out under MA or AE condi-
tions. After 5 h, media from apical and basal compart-
ments were sampled and Stx concentrations were
determined. Initial experiments showed that Stx2 levels in
concentrated basal supernatants were too low to detect
by ELISA. Therefore, the more sensitive VCCA was used
for Stx2 quantification in apical and basal media. Quanti-
fication of apical Stx2 levels after EDL933 and H1121
infection by ELISA and VCCA yielded comparable results
(Fig. S2). As shown in Fig. 7A, Stx2 translocation was
significantly enhanced under MA conditions in EDL933-
infected cells. A similar trend was observed in cells
infected with H1121 although this did not reach signifi-
cance. In addition, Stx2 translocation was significantly
higher after MA infection with EDL933 when compared
with H1121 (Fig. 7A).
To investigate whether enhanced Stx2 translocation
under microaerobiosis could be attributed to physiological
changes in the host cells, subsequent incubations were
performed with either EDL933 or purified Stx2. As shown
in Fig. 7B, there was no significant difference between
translocation of purified Stx2 under AE versus MA condi-
tions. In addition, Stx2 translocation during MA EDL933
infection was significantly increased compared with puri-
fied Stx2 alone (Fig. 7B) indicating a role of the bacterial
infection process in Stx absorption.
Enhanced Stx2 translocation during microaerobic STEC
infection is independent of macropinocytosis
Recent studies have demonstrated STEC-induced Stx
uptake by macropinocytosis (Lukyanenko et al., 2011; In
et al., 2013). To determine whether this pathway was also
involved in Stx translocation in our experimental system,
we investigated several indicators of macropinocytosis.
During morphological examination of STEC-infected
polarized T84 cells described earlier, we did not observe
any signs of membrane ruffling, blebbing or actin reor-
ganization (Fig. 2A and C). In another set of experiments,
polarized T84 cells were incubated with EDL933 or puri-
fied Stx2 under AE or MA conditions and the fluid-phase
marker horseradish peroxidase (HRP) was also added to
the apical medium. As shown in Fig. 8A, translocation of
HRP was not significantly affected by MA infection.
We further investigated the involvement of Src kinase
activation which had been linked to Stx1 macropinocytosis
in earlier studies (Malyukova et al., 2009). Infections with
EDL933 under MAorAE conditions were performed for 4 to
8 h, and T84 cell lysates were examined for Src kinase
phosphorylation by Western blot analysis. As a positive
control, T84 cells were incubated with N-ethylmaleimide
(NEM) for 4 h to induce Src phosphorylation. As shown in
Fig. 8B, neither microaerobiosis nor EDL933 infection trig-
gered Src activation after 8 h of incubation. Similar results
were obtained after shorter incubations of 4 and 6 h (data
not shown).
Fig. 7. Stx2 translocation across polarized T84 cells is enhanced
by STEC infection under MA conditions. T84 cells were apically
incubated with EDL933 (A, B), H1121 (A) or purified Stx2 (B) for
5 h under AE (■) or MA (□) conditions. Stx2 concentrations in
apical and basal media were determined by VCCA. Translocation
rates are expressed as percentage of apical Stx recovered in basal
compartments.
A. Data are shown as means ± SEM from seven independent
experiments performed in duplicate. ***P < 0.001 EDL933 MA
versus AE; &&P < 0.01 H1121 MA versus EDL933 MA.
B. Data are shown as means ± SEM from five independent
experiments performed in duplicate. **P < 0.01 versus AE;
&P < 0.05 versus EDL933 MA.
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Finally, we tested several inhibitors of macropinocytosis
which had previously been shown to decrease Stx1
uptake and/or translocation (Lukyanenko et al., 2011; In
et al., 2013). These included cytochalasin D (inhibitor of
actin polymerization), blebbistatin (inhibitor of non-muscle
myosin II ATPase) and ML 141 (inhibitor of Cdc42
GTPase). Polarized T84 cells were infected with EDL933
for 5 h under MA conditions, and inhibitors were added to
the apical chambers. None of the reagents affected
bacterial growth or Stx release into the medium (data
not shown). However, a significant loss of TER was
observed in cytochalasin D and blebbistatin-treated T84
monolayers (Fig. 8C). This was not observed with DMSO
which was used as a solvent for all reagents (data not
shown). As shown in Fig. 8D, none of the inhibitors sig-
nificantly affected Stx2 translocation across the T84
monolayer.
Discussion
Oxygen levels in the human intestine are considered
anaerobic in the lumen and microaerobic at the mucosal
surface due to oxygen diffusion from the epithelium
(Marteyn et al., 2011). Although it is difficult to determine
accurate oxygen levels in the human gut, data obtained
by non-invasive imaging in the mouse indicate 1.4%
oxygen in the mid-small intestine and colon (He et al.,
1999). Therefore, it is important to consider the influence
of reduced oxygen levels on virulence of intestinal patho-
gens, and several recent studies have demonstrated viru-
lence gene modulation in response to oxygen (Marteyn
et al., 2011). The vertical diffusion chamber system
presented in this study has been successfully used to
demonstrate enhanced adherence, invasion and host
cell response to infection with Helicobacter pylori and
Campylobacter jejuni under microaerobiosis (Cottet et al.,
2002; Mills et al., 2012). In addition, previous studies have
shown that low oxygen concentrations increase STEC
adherence to small and large intestinal epithelial cells by
promoting T3S and expression of Sfp fimbriae (Müsken
et al., 2008; Schüller and Phillips, 2010). In this study, we
have focused on the aspect of Stx interaction with human
colonic epithelium, as STEC pathology is most predomi-
nant in the colon (Tarr et al., 2005). We have used polar-
ized T84 human colon carcinoma cells which like human
intestinal epithelium do not express the Stx receptor Gb3
and are resistant to Stx cytotoxicity (Schüller et al., 2004).
Similar to our previous study with Stx-negative STEC
(TUV 93-0) (Schüller and Phillips, 2010), infection with
wild-type STEC did not cause disruption of barrier func-
tion after 5 h of infection, thereby excluding paracellular
leakage of Stxs through the cell monolayer (Philpott et al.,
1997; Hurley et al., 2001). Adherence patterns of
O157:H7 strains EDL933 and Walla-1 were comparable
Fig. 8. Macropinocytosis is not involved in enhanced Stx2 translocation during microaerobic STEC infection.
A. HRP was added to T84 cells incubated with EDL933 or purified Stx2 for 5 h under AE (■) or MA (□) conditions. HRP concentrations in
apical and basal media were determined by HRP activity assay. Translocation rates are expressed as percentage of apical HRP recovered in
basal compartments. Data are shown as means ± SEM from four independent experiments performed in duplicate.
B. Polarized T84 cells were incubated with EDL933, NEM or left non-infected (NI) for 8 h under aerobic (A) or microaerobic conditions (M).
After separation of cell lysates by SDS-PAGE, phosphorylated (p-Src) and total Src kinase (Src) were detected by Western blotting. Shown
are representative images from two independent experiments performed in duplicate.
C and D. Polarized T84 cells were incubated with EDL933 for 5 h under MA conditions. Apical sides were either left untreated (NT) or
incubated with cytochalasin D (cyt), blebbistatin (ble) or ML141. TER (C) and Stx2 translocation (D) was determined after infection. Data are
shown as means ± SEM from four independent experiments performed in triplicate. ***P < 0.001 versus NT or ML 141.
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to those observed with TUV 93-0 demonstrating small
bacterial microcolonies with localized microvillous efface-
ment (Schüller and Phillips, 2010). In contrast, coloniza-
tion by the O104:H4 isolate H1121 was far more extensive
and revealed formation of bacterial aggregates and
surrounding microvillous vesiculation characteristic for
enteroaggregative E. coli (EAEC) (Hicks et al., 1996;
Nataro et al., 1996). A similar adherence phenotype has
also been described by Bielaszewska et al. (2011) and is
in agreement with the EAEC genetic backbone of
O104:H4 (Rasko et al., 2011).
When we investigated bacterial growth under AE and
MA conditions, growth of all three STEC strains was
reduced under microaerobiosis. E. coli bacteria express
two respiratory oxidases for oxygen reduction. The low-
affinity cytochrome bo3 oxidase is used at high oxygen
levels, whereas the high-affinity cytochrome bd oxidase is
active at low oxygen concentrations but is energetically
less efficient (Gunsalus and Park, 1994; Jones et al.,
2007).
After ingestion via contaminated food or water, STEC
colonize the human intestine and release Stxs. Stxs are
encoded by the late genes of lambdoid prophages and
Stx2 expression and release is mainly regulated by the
late phage promoter pR’ and therefore dependent on the
phage lytic cycle (Wagner et al., 2001b). Spontaneous
prophage induction occurs at very low frequency but a
recent study in germ-free mice has shown that the intes-
tinal environment triggers the Stx2 phage lytic cycle (Tyler
et al., 2013). In vitro studies have identified several
factors which are likely to modulate Stx release in vivo.
Hydrogen peroxide produced by neutrophils and
contact of STEC with intestinal epithelial cells or
macrophages has been shown to enhance Stx2 expres-
sion (Wagner et al., 2001a; Shimizu et al., 2011). In
addition, ethanolamine has been identified as an environ-
mental cue which leads to Stx2 induction in the colon
(Kendall et al., 2012). On the other hand, factors secreted
by human microbiota and nitric oxide generated by acti-
vated intestinal epithelial cells have been shown to inhibit
Stx2 expression and release (Vareille et al., 2007; de
Sablet et al., 2009). Our study using a microaerobic T84
cell infection model shows that low oxygen levels similar
to those in the human intestine suppress Stx2 release into
the medium. This is in agreement with a recent study
which demonstrated lower Stx release by O157 strain
EDL933 in simulated ileal and colonic environment media
under MA versus AE conditions (Polzin et al., 2013). As
Stx2 production and release are inherently linked to the
phage lytic cycle and therefore bacterial lysis and death
(Mühldorfer et al., 1996; Wagner et al., 2001b) it could be
argued that the MA environment in the human gut pro-
motes STEC survival. In addition, in vivo experiments in
mice have demonstrated that the intestinal epithelium is
surrounded by a zone of relative oxygenation resulting
from oxygen diffusion from the villous vasculature
(Marteyn et al., 2010). Although it remains yet to be deter-
mined how much oxygen is present at the epithelial
surface, it could be speculated that this is sufficient to
trigger Stx2 phage lysis and targeted toxin release to the
epithelium.
Whereas STEC strains Walla-1 and H1121 express
Stx2 only, EDL933 also produces Stx1. In our study, Stx1
expression was also reduced under MA versus AE condi-
tions. However, in contrast to Stx2, Stx1 was detected
intracellularly and represented only 2–4% of total Stx
released during infection. This is similar to results
obtained with STEC cultured in broth or cell culture
medium where Stx2 was the main toxin type detected in
the supernatant (Strockbine et al., 1986; Gobert et al.,
2007; Shimizu et al., 2009). The different localization is
likely linked to the different transcriptional regulation of the
two Stx types. Whereas Stx2 transcription is mainly driven
by the late phage promoter pR’ and therefore dependent
on phage induction and bacterial lysis (Wagner et al.,
2001b), Stx1 appears to be predominantly expressed
from the toxin promoter pstx1 which is independent of the
phage lytic cycle so that Stx1 remains localized within the
periplasm (Wagner et al., 2002; Ritchie et al., 2003). Pre-
dominant Stx2 release during STEC infection might
explain why this toxin type is more closely linked to HUS
than Stx1 (Heuvelink et al., 1995; Boerlin et al., 1999).
However, this does not explain why STEC strains
expressing both Stx1 and Stx2 appear less virulent than
strains expressing Stx2 only in some studies (Pickering
et al., 1994) which might be linked to interaction between
Stx1 and Stx2 phage repressors or competition of the two
toxin types for Gb3 binding. In addition, predominant Stx2
release might not always apply in the in vivo situation, and
preferential Stx1 release in faecal filtrates has been
observed in some cases (Cornick et al., 2002).
As STEC are non-invasive, released Stxs have to per-
meate the intestinal epithelial barrier to enter the blood-
stream and cause HUS. In contrast to intestinal and renal
vasculature, human intestinal epithelium does not appear
to express the Stx receptor Gb3 or any other toxin binding
site and is resistant to Stx cytotoxicity (Björk et al., 1987;
Holgersson et al., 1991; Schüller et al., 2004; 2007).
Several routes of Stx transport across the gut epithe-
lium have been proposed (Schüller, 2011) with Gb3-
independent transcytosis being the most investigated
mechanism (Acheson et al., 1996; Philpott et al., 1997;
Hurley et al., 2001; Malyukova et al., 2009). Most of these
studies have been performed with purified Stx1 only but
experiments with Caco-2 cells have demonstrated that
Stx1 and Stx2 are transcytosed by different pathways
(Hurley et al., 1999). This together with the strong asso-
ciation of Stx2 with HUS emphasizes the need for studies
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directed at Stx2. In addition, the use of purified Stx instead
of STEC infection might neglect the following factors
which might be relevant in the in vivo situation. (i) Physi-
ological Stx concentrations during STEC infection in the
human gut are unknown. Therefore, the use of arbitrary
concentrations of purified toxin might lead to artificial
results. (ii) A recent study has suggested that partial
unfolding of Stx1 during multi-step purification methods
may lead to loss of neutrophil binding (Brigotti et al.,
2011). Therefore, it is possible that changes in Stx con-
formation could also affect uptake and transcytosis. (iii)
Stxs can be released from STEC within outer membrane
vesicles (OMVs) (Kolling and Matthews, 1999), and the
enclosure within a lipid bilayer may affect the mechanism
of uptake and transcytosis. (iv) STEC infection might
modify Stx uptake and translocation. In addition to inves-
tigating Stx2 translocation during STEC infection, we
have also determined the influence of a MA environment
similar to that in the human gut on this process. Translo-
cation levels of purified Stx2 in our system were compa-
rable to those published previously (0.02–0.04% after
5 h compared with 0.02% after 4 h respectively) (Hurley
et al., 2001). In addition, no significant differences were
observed between AE and MA conditions indicating that
oxygen does not directly affect host cell transcytosis.
While similar translocation rates were obtained during AE
infection with EDL933, Stx absorption was significantly
enhanced during MA infection. Together these results
suggest that MA conditions may induce bacterial factors
which promote Stx transcytosis. It is tempting to speculate
that this could be related to the T3SS and its effector
proteins which have been shown to profoundly affect host
cell signalling (Croxen and Finlay, 2010). This would be
supported by the observation that MA infection with H1121
which does not express an STEC T3SS, does not signifi-
cantly enhance Stx absorption. In addition, our previous
studies have shown enhanced T3S under microaerobiosis
(Schüller and Phillips, 2010).
Very few other studies have been conducted to date to
investigate the influence of STEC infection on Stx translo-
cation. All studies have been performed under AE condi-
tions and the results are contradictory. While Philpott and
colleagues have demonstrated that translocation of puri-
fied Stx1 across polarized T84 cells is not altered by
simultaneous infection with an Stx-negative STEC labora-
tory variant (Philpott et al., 1997), recent studies have
shown stimulation of uptake and/or transcytosis of purified
Stx1 by incubation with STEC Stx-deletion mutants or
lysates (Lukyanenko et al., 2011; In et al., 2013). These
latter studies have postulated macropinocytosis as mecha-
nism of Stx transport which is supported by formation of
actin-rich macropinocytic blebs at apical cell surfaces,
localization of Stx in large actin-coated vesicles, and
dependence on non-muscle myosin II and Cdc42
(Malyukova et al., 2009; Lukyanenko et al., 2011; In et al.,
2013). In contrast, we did not detect any signs of
macropinocytosis during STEC infection, and none of the
inhibitors used affected Stx2 translocation. Although
cytochalasin D and blebbistatin caused a loss of T84 cell
barrier function as described previously (Madara et al.,
1988; Ivanov et al., 2005), this did not result in obvious
paracellular Stx leakage. It is unlikely that any inhibitory
effect of cytochalasin D on Stx transcytosis might be
masked by increased paracellular permeability as previous
studies have shown maintenance of size restriction in
cytochalasin D-treated T84 cells (Madara et al., 1988). The
discrepancy between our study and those by Kovbasnjuk
and colleagues might be due to several factors which
include Stx type (Stx2 versus Stx1) and focus on translo-
cation versus uptake which might not be necessarily cor-
related. In addition, there are differences in experimental
protocols. In our study, we have used wild-type STEC
instead of co-incubations of arbitrary levels of purified Stx
administered together with Stx-negative STEC. Therefore,
Stx concentration, conformation as well as degree of asso-
ciation with OMVs are more likely to parallel the in vivo
situation. In addition, the use of fluorescent tags to label
Stx might interfere with biological properties of the con-
jugate toxins. Furthermore, the morphology of the T84
monolayers appears different in XZ confocal scans which
might indicate a different polarization status.
In addition to infection with STEC O157:H7, we have
also included an O104:H4 isolate (H1121) from an STEC
outbreak in Germany in 2011. This outbreak has been the
most severe recorded to date and has affected around
4000 people. The unusually high rate of HUS (22%) sug-
gests increased bacterial virulence (Bielaszewska et al.,
2011). As mentioned earlier, adherence of H1121 to polar-
ized T84 cells was considerably enhanced compared with
the two O157:H7 strains tested. Although microaerobiosis
had a similar effect on H1121 compared with O157
strains, amounts of Stx2 released during infection and
translocation rates across epithelial monolayers were sig-
nificantly lower compared with EDL933. Both strains
express the same Stx2 subtype (Stx2a). These results
suggest that augmented virulence of H1121 is not related
to increased Stx expression and transcytosis in vivo but is
more likely caused by its increased ability to adhere and
colonize the human colon. This in turn might lead to
enhanced tissue damage due to bacterial factors and the
host inflammatory response and thereby promote Stx
leakage into the systemic circulation.
In summary, we have demonstrated that a microaerobic
environment similar to that in the human gut modulates
Stx production, release and translocation during colonic
STEC infection. Our observations suggest that low
oxygen levels induce STEC factors which promote Stx2
transcytosis across human colonic epithelium. Identifica-
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tion of these factors will remain the challenge for future
studies and will lead to a better understanding of Stx
absorption into the systemic circulation.
Experimental procedures
Cell culture
Human colon carcinoma T84 cells (ATCC CCL-248) were cul-
tured in DMEM/F-12 mixture supplemented with 10% fetal bovine
serum (FBS, Sigma) and used between passage 42 and 65. For
diffusion chamber experiments, 5 × 105 T84 cells cm−2 were
seeded on collagen-coated Snapwell filter inserts (12 mm diam-
eter, 0.4 μm pore; Corning Costar). TER was monitored using an
EndOhm chamber and EVOM resistance meter (WPI) and values
of 1000 to 1500 Ω × cm2 after 12–18 days of differentiation indi-
cated establishment of epithelial barrier function. African Green
monkey kidney Vero cells (ECACC 84113001) were cultured in
DMEM supplemented with 10% FBS. All cells were grown at
37°C in a 5% CO2 atmosphere.
Bacterial strains and culture conditions
STEC prototype strain O157:H7 EDL933 [Stx1a+, Stx2a+; isolate
from 1982 outbreak in Michigan/Oregon (Riley et al., 1983)] and
strain O157:H7 Walla-1 [(Stx2a+; isolate from 1986 outbreak in
Walla Walla, Washington state (Ostroff et al., 1990)] were pro-
vided by Roberto La Ragione (University of Surrey, Guildford).
STEC O104:H4 strain H1 1218 0280 (Stx2a+; isolate from the
2011 outbreak in Germany) was obtained from Geraldine Smith
(Public Health England, London Colindale). Bacteria were grown
standing in LB broth overnight at 37°C. Bacteria were spun down
before infection and suspended in serum-free culture medium.
Infection in a vertical diffusion chamber system
Experiments in VDCs (Harvard Apparatus) were performed as
described previously (Schüller and Phillips, 2010) with the follow-
ing modifications. Polarized T84 cells were infected apically with
approximately 107 bacteria. Apical chambers were perfused with
air, 5% CO2 (aerobic) or 90% N2, 5% H2, 5% CO2 (anaerobic)
whereas basal compartments were kept under aerobic condi-
tions. Oxygen concentrations in apical compartments were moni-
tored during the experiment using an ISO2 dissolved oxygen
meter (WPI). Chambers perfused with air demonstrated oxygen
levels of 18–20% of atmospheric pressure whereas 1.4–1.7%
was detected in chambers gassed with anaerobic gas mixture.
For some VDC experiments, 100 ng ml−1 purified Stx2 (Anne
Kane, Tufts Medical Center, Boston, USA), 200 μM NEM,
10 μg ml−1 type VI-A HRP, 1 μM cytochalasin D, 50 μM
blebbistatin, or 10 μM ML 141 (Sigma) were added to the apical
chamber. Incubations were performed for 3–8 h without medium
change. At the end of the experiment, apical media were col-
lected and OD600 values were determined to assess growth of
non-adherent bacteria. Bacteria were pelleted by centrifugation
and supernatants and pellets were stored at −20°C until further
analysis. Basal media were concentrated with Amicon Ultra cen-
trifugal filter units (Millipore) and stored at −20°C. Membrane
filters were cut out from supports, washed twice in cold PBS to
remove non-adherent bacteria and processed according to
further analysis.
SEM
T84 cells on filters were fixed with 2.5% glutaraldehyde in 0.1 M
phosphate buffer and dehydrated through graded acetone series.
Specimens were dried using tetramethylsilane (Sigma), mounted
on aluminium stubs, sputter-coated with gold (Polaron SC7640
sputter coater, Quorum Technologies), and viewed with a JEOL
JSM 4900 LV or Zeiss Supra 55 VP FEG scanning electron
microscope.
Immunofluorescence staining
T84 cells on filters were fixed in 3.7% formaldehyde in PBS for
10 min and blocked/permeabilized with 0.1% Triton X-100 (Tx-
100) and 0.5% BSA in PBS for 20 min. For occludin staining, cells
were pre-extracted as recommended by the manufacturer. Cells
were subsequently incubated in primary antibodies (polyclonal
goat anti-E. coli from abcam, polyclonal rabbit anti-occludin from
Invitrogen) for 60 min, washed and incubated in Alexa Fluor-
conjugated anti-goat or anti-rabbit IgG (Invitrogen) for 30 min.
Cell nuclei/bacterial DNA and filamentous actin were labelled with
DAPI (Roche) and FITC-conjugated phalloidin (Sigma) respec-
tively. Filters were mounted in Vectashield (Vector Laboratories)
and analysed using a fluorescence light microscope (Axio
Imager, Zeiss) or confocal laser scanning microscope (LSM 510
Meta, Zeiss).
SDS-PAGE and Western blot analysis
Bacterial lysates were prepared by suspending bacterial pellets
in reducing SDS-PAGE sample buffer. Volumes were adjusted
according to bacterial density (OD600). For cell lysates, T84
monolayers were lysed in ice-cold RIPA buffer containing 1 mM
PMSF, 1 mM Na3VO4 and protease inhibitor cocktail (1:200,
Sigma). Samples were resolved on 12% SDS-polyacrylamide
gels and proteins were transferred to PVDF membranes (GE
Healthcare). Membranes were blocked with 5% skimmed milk in
TBS/0.05% Tween-20 for 60 min and incubated with primary
antibodies (mouse anti-Stx1A and anti-Stx2A from the
Biodefense and Emerging Infections Research Resources
Repository, NIAID, NIH; rabbit anti-GroEL from Sigma; mouse
anti-Src and anti-p-Src from Millipore) overnight at 4°C. After
washing, blots were incubated with HRP-conjugated goat anti-
rabbit or anti-mouse IgG (Sigma) and developed using enhanced
chemiluminescence (Immobilon Western, Millipore) and a
FluorChem E Imager (ProteinSimple).
ELISA
Stx in apical supernatants was quantified using a sandwich
ELISA as described previously (Acheson et al., 1990). Microtitre
plates were coated with P1 glycoprotein (Anne Kane, Tufts
Medical Center, Boston, USA) and Stx1 and Stx2 were detected
using mouse monoclonal antibodies (Biodefense and Emerging
Infections Research Resources Repository, NIAID, NIH).
Vero cell cytotoxicity assay
Apical and concentrated basal supernatants were filter sterilized
and 50 μl sample were pipetted into a 96 well culture plate. For
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neutralization assays, Stx1- or Stx2-specific antibodies were
added at a final dilution rate of 1:500 and plates were incubated
at 37°C for 90 min to allow Stx-antibody binding. Vero cells were
added to each sample (2 × 104 cells in 100 μl) and plates were
incubated for 72 h at 37°C in a 5% CO2 atmosphere. Cells
were washed with PBS, fixed in 3.7% formaldehyde in PBS and
stained with 0.1% (w/v) crystal violet in 10% ethanol for 20 min.
After elution of the dye in 50% EtOH, crystal violet staining was
quantified at OD595. When comparing Stx release between differ-
ent strains or oxygen levels, Stx concentrations in supernatants
were adjusted to OD 0.1 or OD 1.0 to account for different
bacterial densities in apical media.
HRP activity assay
Apical and concentrated basal supernatants (20 μl) were incu-
bated with 200 μl HRP reagent (50 mM NaH2PO4, pH 5.0;
0.1 mg ml−1 o-dianisidine, 0.003% (w/v) H2O2) for 20 min in the
dark. The reaction was quantified at OD450 versus OD630.
Statistics
Statistical analysis was performed using GraphPad Prism 6 soft-
ware. Student’s paired t-test was used to determine differences
between two groups. One-way or two-way ANOVA with Tukey’s
multiple comparisons test was used for multiple groups. A
P-value of < 0.05 was considered significant.
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Supporting information
Additional Supporting Information may be found in the online
version of this article at the publisher’s web-site:
Fig. S1. Stx2 is the main toxin type released during infection
with EDL933. Undiluted apical supernatants (SN ud) or superna-
tants diluted 1:10 (SN 1:10) from EDL933-infected T84 cells were
incubated with anti-Stx1, anti-Stx2 or medium control (no Ab)
before Vero cells were added. Vero cell cytotoxicity is evident in
SN samples without antibodies and with anti-Stx1 but not with
anti-Stx2.
Fig. S2. Correlation of Stx2 concentrations determined by
ELISA and VCCA. Polarized T84 cells were infected for 5 h under
AE (■) or MA (□) conditions. Stx2 levels in apical supernatants
were quantified by sandwich ELISA or VCCA. Data are shown as
means ± SEM from three independent experiments performed in
duplicate.
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